InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 73451

Sunday, 09/22/2013 7:13:36 AM

Sunday, September 22, 2013 7:13:36 AM

Post# of 146240
But then, Nanoviricides, Inc. may still announce "Tox" studies "began in ..." because of the sentence in "bold"...it is still an event that is conducted by BASi with the "injectable FluCide" drug produced/supplied.

The Company will be able to initiate GLP Safety/Toxicology studies (“Tox Package”) studies of the injectable FluCide drug when the requisite large amount of drug substance is produced.

I believe batches of drug substance are continuously being produced, shipped and seamlessly the "Tox studies" have begun. Perhaps someone posting here, that has worked in a lab (GLP), may confirm this is possible. I'm speculating here. Nanoviricides, Inc. will nevertheless include this in a PR because it is an ongoing process that leads to an important catalyst, "initial results". Monday is only hours away. Best to all!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News